Logo image
Sign in
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel
Journal article   Peer reviewed

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel

Michele A. Faulkner and Rachel A. Burke
Expert Opinion on Drug Safety, Vol.12(6), pp.847-855
11/2013
PMID: 23883095

Metrics

4 Record Views

Details